These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9731502)

  • 41. Immune surveillance against a solid tumor fails because of immunological ignorance.
    Ochsenbein AF; Klenerman P; Karrer U; Ludewig B; Pericin M; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2233-8. PubMed ID: 10051624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expansion of murine cytotoxic precursors in vitro and in vivo by purified interleukin-2.
    Merluzzi VJ; Last-Barney K
    J Biol Response Mod; 1984 Oct; 3(5):468-74. PubMed ID: 6334134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection.
    Badovinac VP; Haring JS; Harty JT
    Immunity; 2007 Jun; 26(6):827-41. PubMed ID: 17555991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy.
    Matsui K; O'Mara LA; Allen PM
    Int Immunol; 2003 Jul; 15(7):797-805. PubMed ID: 12807818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy.
    Kanagawa N; Yanagawa T; Nakagawa T; Okada N; Nakagawa S
    Cancer Gene Ther; 2013 Jan; 20(1):57-64. PubMed ID: 23175243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutting edge: competition for APC by CTLs of different specificities is not functionally important during induction of antiviral responses.
    Probst HC; Dumrese T; van den Broek MF
    J Immunol; 2002 Jun; 168(11):5387-91. PubMed ID: 12023329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity.
    Wilde S; Sommermeyer D; Frankenberger B; Schiemann M; Milosevic S; Spranger S; Pohla H; Uckert W; Busch DH; Schendel DJ
    Blood; 2009 Sep; 114(10):2131-9. PubMed ID: 19587379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-avidity T cells are preferentially tolerized in the tumor microenvironment.
    Zhu Z; Singh V; Watkins SK; Bronte V; Shoe JL; Feigenbaum L; Hurwitz AA
    Cancer Res; 2013 Jan; 73(2):595-604. PubMed ID: 23204239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.
    Leisegang M; Engels B; Schreiber K; Yew PY; Kiyotani K; Idel C; Arina A; Duraiswamy J; Weichselbaum RR; Uckert W; Nakamura Y; Schreiber H
    Clin Cancer Res; 2016 Jun; 22(11):2734-43. PubMed ID: 26667491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Naïve cytotoxic T lymphocytes spontaneously acquire effector function in lymphocytopenic recipients: A pitfall for T cell memory studies?
    Oehen S; Brduscha-Riem K
    Eur J Immunol; 1999 Feb; 29(2):608-14. PubMed ID: 10064077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TCR gamma delta cells--minor redundant T cell subset or specialized immune system component?
    Bluestone JA; Matis LA
    J Immunol; 1989 Mar; 142(6):1785-8. PubMed ID: 2646373
    [No Abstract]   [Full Text] [Related]  

  • 52. Antitumor progenitor exhausted CD8
    Lan X; Mi T; Alli S; Guy C; Djekidel MN; Liu X; Boi S; Chowdhury P; He M; Zehn D; Feng Y; Youngblood B
    Nat Immunol; 2024 Jun; 25(6):1046-1058. PubMed ID: 38816618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escape.
    Kaluza KM; Kottke T; Diaz RM; Rommelfanger D; Thompson J; Vile R
    Hum Gene Ther; 2012 Oct; 23(10):1054-64. PubMed ID: 22734672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance.
    Nguyen LT; Elford AR; Murakami K; Garza KM; Schoenberger SP; Odermatt B; Speiser DE; Ohashi PS
    J Exp Med; 2002 Feb; 195(4):423-35. PubMed ID: 11854356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of p53 Augments Antitumor Functions in Cytolytic T Cells.
    Banerjee A; Thyagarajan K; Chatterjee S; Chakraborty P; Kesarwani P; Soloshchenko M; Al-Hommrani M; Andrijauskaite K; Moxley K; Janakiraman H; Scheffel MJ; Helke K; Armenson K; Palanisamy V; Rubinstein MP; Mayer EG; Cole DJ; Paulos CM; Christina-Voelkel-Johnson ; Nishimura MI; Mehrotra S
    Cancer Res; 2016 Sep; 76(18):5229-5240. PubMed ID: 27466285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A method for the generation of TCR retrogenic mice.
    Kieback E; Hilgenberg E; Fillatreau S
    Methods Mol Biol; 2014; 1193():117-26. PubMed ID: 25151002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of an operation on the immunoreactivity indices, their postoperative dynamics and the effect of 3-HAA-antigen on these indices in patients with gastrointestinal tumors].
    Korosteleva TA; Pavlov KA; Mel'nikov RA; Saprin AN; Belokhvostova AT
    Vopr Onkol; 1985; 31(6):52-60. PubMed ID: 4024547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting self-antigens through allogeneic TCR gene transfer.
    de Witte MA; Coccoris M; Wolkers MC; van den Boom MD; Mesman EM; Song JY; van der Valk M; Haanen JB; Schumacher TN
    Blood; 2006 Aug; 108(3):870-7. PubMed ID: 16861342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a cross-reactive self ligand in virus-mediated autoimmunity.
    Ohteki T; Hessel A; Bachmann MF; Zakarian A; Sebzda E; Tsao MS; McKall-Faienza K; Odermatt B; Ohashi PS
    Eur J Immunol; 1999 Sep; 29(9):2886-96. PubMed ID: 10508263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96.
    Janetzki S; Blachere NE; Srivastava PK
    J Immunother; 1998 Jul; 21(4):269-76. PubMed ID: 9672848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.